(Q35794844)

10 August 2017

1 reference

title

Infection, immune function, and functional gut disorders (English)

1 reference

10 August 2017

1 reference

Robin C Spiller

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Clinical Gastroenterology and Hepatology

10 August 2017

published in

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

445-455

1 reference

Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Special considerations of the overactive bladder in children

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Basic and clinical aspects of visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Visceral perception: inflammatory and non-inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

P2X receptors mediate ATP-induced primary nociceptive neurone activation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Vanilloid receptor 1 immunoreactivity in inflamed human bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Impaired sympathetic nerve function in the inflamed rat intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

The effect of nematode infection upon intestinal smooth muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Effects of injury and inflammation on pulpal and periapical nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Nerve growth factor and its high-affinity receptor in chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Regulation of nociceptive neurons by nerve growth factor and glial cell line derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Nerve growth factor induces P2X(3) expression in sensory neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Autonomic neuropathy and immunological abnormalities in Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

The spectrum of autoimmune autonomic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastric emptying of liquid in children suffering from acute rotaviral gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Postviral gastroparesis: presentation, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Evolution of acute cytomegalovirus gastritis to chronic gastrointestinal dysmotility in a nonimmunocompromised adult

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Transient gastroparesis associated with cutaneous herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Disturbed gastric motor activity in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Inflammatory causes of gastroparesis: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Intravenous interleukin-1-beta-induced inhibition of gastric emptying: involvement of central corticotrophin-releasing factor and prostaglandin pathways in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Damage to jejunal intrinsic autonomic nerves in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastric pacing is a new surgical treatment for gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Role of impaired gastric accommodation to a meal in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Activation of the mucosal immune system in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Terminal ileal mucosal mast cells in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Damage to the enteric nervous system in experimental colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Demonstration of varicella-zoster virus infection in the muscularis propria and myenteric plexi of the colon in an HIV-positive patient with herpes zoster and small bowel pseudo-obstruction (Ogilvie's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Hymenolepis diminuta: changes in intestinal morphology and the enterochromaffin cell population associated with infection in male C57 mice

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Effects of serotonin on intestinal secretion and motility

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Increased mast cells in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Symptoms of irritable bowel syndrome in ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Gastrointestinal motility in patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Changes in neuropeptide‐containing nerves in human colonic mucosa with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Substance P containing nerve fibers in rectal mucosa of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Neurochemical coding in the small intestine of patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Adynamic ileus in severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Neuroimmune appendicitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Expression of neuropeptides in normal and abnormal appendices

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Cross linking of collagen is increased in colonic diverticulosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Origin of symptoms in diverticular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Patterns of pain in diverticular disease and the influence of acute diverticulitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900159-4

7 January 2021

10.1016/S1542-3565(04)00159-4

Identifiers

DOI

1 reference

10 August 2017

1 reference